Comprehensive efficacy of ipragliflozin on various conditioned type 2 diabetes compared with dipeptidyl peptidase-4 inhibitors and with both agents, based on a real-world multicenter trial
Fumio Sawano
◽
Nozomu Kamei
◽
Mitsue Miyahara
◽
Kyoko Kobuke
◽
Shuhei Nakanishi
◽
...
2018 ◽
Vol 85
◽
pp. 14-22
◽
Yeon Young Cho
◽
Sung-Il Cho
Iskandar Idris
◽
Ruiqi Zhang
◽
Jil Billy Mamza
◽
Mike Ford
◽
Tamsin Morris
◽
...
2017 ◽
Vol 28
(8)
◽
pp. 2421-2428
◽
S. Dombrowski
◽
K. Kostev
◽
L. Jacob
2016 ◽
Vol 32
(6)
◽
pp. 1087-1096
◽
Sarah Thayer
◽
Wing Chow
◽
Stephanie Korrer
◽
Richard Aguilar
Oyepeju Ogundipe
◽
Mohsen Mazidi
◽
Ken Lee Chin
◽
Deval Gor
◽
Andrew McGovern
◽
...
2021 ◽
Vol 116
◽
pp. 154606
Iskandar Idris
◽
Ruiqi Zhang
◽
Jil Billy Mamza
◽
Mike Ford
◽
Tamsin Morris
◽
...
2020 ◽
Vol 69
(Supplement 1)
◽
pp. 2209-PUB
XI TAN
◽
LINGFENG YANG
◽
KAMLESH KHUNTI
◽
RUYA ZHANG
◽
DIANA ZHANG
◽
...
2015 ◽
Vol 22
(13)
◽
pp. 1573-1581
◽
E. Matteucci
◽
O. Giampietro
2019 ◽
Vol 81
(4)
◽
pp. AB47
Close
Export Citation Format
Close
Share Document
Close